Epic expands hyperCORE’s U.S. footprint with multi-state capabilities, advanced Phase I infrastructure, and deep expertise across high-demand therapeutic areas
LAKE MARY, FL, August 05, 2025 /24-7PressRelease/ — hyperCORE International is pleased to welcome Epic Medical Research, based in Dallas, Texas, to its global partner site network, as the clinical research organization continues to expand its expansive footprint and capabilities through strategic partnerships.
Epic Medical Research operates across 12 state-of-the-art locations in four states, offering full-spectrum clinical trial capabilities across a broad range of therapeutic areas—including metabolic disorders, fatty liver disease (NASH), sleep apnea, obesity, endocrine disorders, pulmonary and gastrointestinal diseases, neurological and psychiatric conditions, pediatrics, rheumatology, dermatology, podiatry, and infectious diseases. With two advanced Phase I units, an on-site sleep lab, and a dedicated laboratory for end-to-end PBMC processing, Epic provides the infrastructure and scientific expertise required to support trials from early development through late-phase execution.
“Joining hyperCORE International marks a transformative step forward for Epic Medical Research,” shared Dr. Haresh Boghara, President & Principal Investigator at Epic. “We are thrilled to be part of a collaborative network that shares our commitment to advancing clinical research and improving patient outcomes. By aligning with hyperCORE, we gain access to greater resources, shared expertise, and a broader platform to deliver high-quality, efficient, and innovative clinical trial solutions.”
“Epic Medical Research brings an impressive combination of therapeutic breadth and operational scale to our global site network,” said Nicholas Focil, President of hyperCORE International and CEO at FOMAT Medical Research, also part of the hyperCORE partner site network. “Their deep commitment to quality and innovation aligns perfectly with hyperCORE’s mission to provide elevated trial performance across our collaborative network of clinical research partners. We’re proud to welcome Epic as a partner and look forward to the collaborative impact we’ll make together in delivering streamlined operations and accelerated results across clinical research.”
Founded in 2019, hyperCORE International is a partner site network of leading clinical research site organizations. Boasting over 80 active trial sites across five countries and two continents, hyperCORE’s partners have jointly completed 7,000+ studies involving over 140,000 randomized participants. Each partner member operates independently but integrates harmonized operational frameworks to optimize efficiency, standardization, and excellence.
hyperCORE remains committed to advancing clinical research through safe, ethical, timely studies; efficient enrollment; and superior retention—empowered by its members’ top-tier awards for performance, quality, and innovation.
—
For the original version of this press release, please visit 24-7PressRelease.com here
